As part of your daily routine as an active trader or investor, it's important to track the stocks in the market that are making the biggest percentage gains and the biggest percentage losses.

Stocks that are making large moves to the upside are favorites among short-term traders who want to capture some of that massive volatility. Stocks that are making big-percentage moves are usually in play because their sector is becoming attractive or they have a major fundamental catalyst such as a recent earnings release. Sometimes stocks making big moves have been hit with an analyst upgrade or an analyst downgrade.

Stocks that are in favor and making large moves is a segment of the market that I tweet about on a regular basis.These are also the exact type of stocks that I love to trade and alert to my subscribers in real-time.

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits. If you time your trade correctly, combining with fundamental trends, discipline and sound money management, you will be well on your way to investment success.

With that in mind, let's take a closer look at a several stocks under $10 that are making large moves to the upside.

Baytex Energy

  • Tuesday's Range: $5.55-$5.78
  • 52-Week Range: $1.08-$13.80
  • Tuesday's Volume: 2.8 million
  • Three-Month Average Volume: 3.23 million

Baytex Energy  (BTE - Get Report) , an oil and gas company, engages in the acquisition, development, exploitation and production of oil and natural gas in the Western Canadian Sedimentary Basin and the U.S. This stock traded up 6% to $5.77 in Tuesday's trading session.

From a technical perspective, Baytex Energy ripped sharply higher on Tuesday back above its 20-day moving average of $5.67 a share with decent upside volume flows. This stock has been trending sideways and consolidating over the last month and change, with shares moving between $4.93 on the downside and $6.20 on the upside. Shares of Baytex Energy are now starting to trend within range of triggering a big breakout trade above the upper-end of its recent sideways trending chart pattern. That trade will trigger if this stock manages to take out some near-term overhead resistance levels at $6 to $6.18 a share and then above more resistance at $6.20 a share with high volume.

Traders should now look for long-biased trades in Baytex Energy as long as it's trending above some near-term support at $5.42 a share or above its 50-day moving average of $5.30 a share and then once it sustains a move or close above those breakout levels with volume that registers near or above 3.23 million shares. If that breakout fires off soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $6.50 to $7.14, or even $7.50 to $8 a share.

Encana

  • Tuesday's Range: $7.81-$8.22
  • 52-Week Range: $3.00-$10.08
  • Tuesday's Volume: 17.22 million
  • Three-Month Average Volume: 14.84 million

Encana  (ECA - Get Report) , together with its subsidiaries, engages in the development, exploration, production and marketing of natural gas, oil and natural gas liquids in Canada and the U.S. This stock closed up 6.1% to $8.09 in Tuesday's trading session.

From a technical perspective, Encana ripped sharply higher on Tuesday back above its 20-day moving average of $7.90 a share with strong upside volume flows. This stock recently formed a triple bottom chart pattern, after shares found some buying interest at $7.46, $7.22 and $7.34 a share over the last month and change. Following that potential bottom, shares of Encana have now started to trend higher and move within range of triggering a big breakout trade above some key overhead resistance levels. That trade will trigger if this stock manages to take out Tuesday's intraday high of $8.22 a share and then above some near-term overhead resistance at $8.53 a share with high volume.

Traders should now look for long-biased trades in Encana as long as it's trending above Tuesday's intraday low of $7.81 a share or above its 50-day moving average of $7.60 a share and then once it sustains a move or close above those breakout levels with volume that hits near or above 14.84 million shares. If that breakout hits soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $9.02 to $9.09, or even its 52-week high of $10.08 a share.

CPI Card Group

  • Tuesday's Range: $4.47-$4.84
  • 52-Week Range: $3.38-$13.50
  • Tuesday's Volume: 381,000
  • Three-Month Average Volume: 280,411

CPI Card Group  (PMTS - Get Report) , together with its subsidiaries, engages in the design, production, data personalization, packaging and fulfillment of financial payment cards. This stock traded up 6% to $4.75 in Tuesday's trading session.

From a technical perspective, CPI Card Group ripped sharply higher on Tuesday right off some near-term support at $4.45 a share with strong upside volume flows. This stock recently formed a double bottom chart pattern, after shares found some buying interest at $4.30 to$4.45 a share over the last few weeks. Following that potential bottom, shares of CPI Card Group have now started to rip higher and move within range of triggering a major breakout trade. That trade will trigger if this stock manages to take out its 50-day moving average of $4.96 a share and then once it clears more key resistance at $5.08 a share with high volume.

Traders should now look for long-biased trades in CPI Card Group as long as it's trending above those recent double bottom support levels and then once it sustains a move or close above those breakout levels with volume that hits near or above 280,411 shares. If that breakout hits soon, then this stock will set up to re-fill some of its previous gap-down-day zone from May that started near $8 a share.

Marinus Pharmaceuticals

Marinus Pharmaceuticals  (MRNS) , a clinical stage biopharmaceutical company, focuses on developing and commercializing therapeutics to treat epilepsy and neuropsychiatric disorders. This stock traded up 12.3% to $1.55 in Tuesday's trading session.

Tuesday's Range: $1.36-$1.56
52-Week Range: $1.19-$20.72
Tuesday's Volume: 541,000
Three-Month Average Volume: 349,511

From a technical perspective, Marinus Pharmaceuticals exploded sharply higher on Tuesday right off some near-term support at $1.35 a share and back above its 20-day moving average of $1.40 a share with strong upside volume flows. This high-volume rip to the upside is now quickly pushing shares of Marinus Pharmaceuticals within range of triggering a big breakout trade above some key overhead resistance levels. That trade will trigger if this stock manages to take out Tuesday's intraday high of $1.56 a share and then once it clears more key resistance at $1.60 a share with high volume.

Traders should now look for long-biased trades in Marinus Pharmaceuticals as long as it's trending above its 20-day moving average of $1.40 a share or above more near-term support at $1.35 a share and then once it sustains a move or close above those breakout levels with volume that hits near or above 349,511 shares. If that breakout develops soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $1.81 to its gap-down-day high from June near $2 a share. Any high-volume move above $2 will then give this stock a chance to re-fill some of its previous gap-down-day zone that started near $5.50 a share.

EnteroMedics

  • Tuesday's Range: $0.27-$0.34
  • 52-Week Range: $0.24-$6.75
  • Tuesday's Volume: 634,000
  • Three-Month Average Volume: 226,241

EnteroMedics  (ETRM) , a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders. This stock traded up 6.3% to 31 cents per share in Tuesday's trading session.

From a technical perspective, EnteroMedics sharply higher on Tuesday right off some near-term support at 27 cents per share with strong upside volume flows. This high-volume rip to the upside briefly pushed this stock back above its 20-day moving average of 33 cents per share, before it closed just below that level at 31 cents per share. This move is now quickly pushing shares of EnteroMedics within range of triggering a big breakout trade above some key near-term overhead resistance levels. That trade will trigger if this stock manages to take out some near-term overhead resistance levels at 34 to 35 cents per share with high volume.

Traders should now look for long-biased trades in EnteroMedics as long as it's trending above some near-term support at 27 cents per share and then once it sustains a move or close above those breakout levels with volume that hits near or above 226,241 shares. If that breakout materializes soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at 40 to 45 cents, or even 50 cents to its 50-day moving average of 51 cents per share.

Chesapeake Energy

  • Tuesday's Range: $4.28-$4.59
  • 52-Week Range: $1.50-$11.69
  • Tuesday's Volume: 38.69 million
  • Three-Month Average Volume: 41.45 million

Chesapeake Energy  (CHK - Get Report)  engages in the acquisition, exploration, and development of properties for the production of oil, natural gas, and natural gas liquids from underground reservoirs in the U.S. This stock traded up 9.5% to $4.58 in Tuesday's trading session.

From a technical perspective, Chesapeake Energy ripped sharply higher on Tuesday back above both its 20-day moving average of $4.38 a share and its 50-day moving average of $4.43 a share with decent upside volume flows. This move is now quickly pushing shares of Chesapeake Energy within range of triggering a major breakout trade above some key near-term overhead resistance levels. That trade will trigger if this stock manages to clear some near-term overhead resistance levels at $4.63 to $4.82 a share and then once it takes out more resistance levels at its 200-day moving average of $4.90 a share to $5.14 a share with high volume.

Traders should now look for long-biased trades in Chesapeake Energy as long as it's trending above Tuesday's intraday low of $4.28 a share and then once it sustains a move or close above those breakout levels with volume that hits near or above 41.45 million shares. If that breakout takes hold soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $5.50 to $6, or even $6.50 to $7 a share.

Ampio Pharmaceuticals

  • Tuesday's Range: $0.89-$1.05
  • 52-Week Range: $0.84-$4.32
  • Tuesday's Volume: 1.81 million
  • Three-Month Average Volume: 781,180

Ampio Pharmaceuticals  (AMPE) , a biopharmaceutical company, focuses on developing therapies for the treatment of prevalent inflammatory conditions in the U.S. This stock traded up 9.4% to $1.04 in Tuesday's trading session.

From a technical perspective, Ampio Pharmaceuticals ripped sharply higher on Tuesday right above its new 52-week low of 84 cents per share with strong upside volume flows. This high-volume rip to the upside is now quickly pushing shares of Ampio Pharmaceuticals within range of triggering a major breakout trade above some key near-term overhead resistance levels. That trade will trigger if this stock manages to take out some key overhead resistance levels at $1.05 to around $1.10 a share with high volume.

Traders should now look for long-biased trades in Ampio Pharmaceuticals as long as it's trending above Tuesday's intraday low of 89 cents per share or above its new 52-week low of 84 cents per share and then once it sustains a move or close above those breakout levels with volume that hits near or above 781,180 shares. If that breakout fires off soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $1.25 to its gap-down-day high from June around $1.50 a share. Any high-volume move above $1.50 will then give this stock a chance to re-fill some of its previous gap-down-day zone from June that started near $3.50 a share.

Disclosure: This article is commentary by an independent contributor. At the time of publication, the author held no positions in the stocks mentioned.